IBE-814 Intravitreal Implant

dexamethasone · Ripple Therapeutics Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBE-814 Intravitreal Implant, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of IBE-814 Intravitreal (IVT) Implant - a Sustained, Low Dose Dexamethasone Therapy [Phase 2]